Liver Cancer:
Liver Cancer, Symptoms of Liver Cancer and Treatment News.
-
Apr 29th, 2008
Genomics improves our ability to target experimental liver cancer treatments.
-
Apr 25th, 2008
Treatment with sunitinib slows tumor growth and reduces the risk of metastasis in patients with hepatocellular carcinoma, an aggressive cancer of the liver.
-
Apr 23rd, 2008
Treatment with sunitinib slows tumor growth and reduces the risk of metastasis in patients with hepatocellular carcinoma, an aggressive cancer of the liver.
-
Nov 19th, 2007
Nexavar becomes the first FDA-approved drug treatment therapy for patients suffering from liver cancer. Nexavar is made by Bayer Healthcare and the FDA liver cancer treatment node was announced today.
-
Nov 3rd, 2007
Progen Pharmaceuticals awarded to PI-88 for the prevention of tumour recurrence following curative resection of primary liver cancer and in order to commence the Phase 3 program as rapidly as possible, the Company will no longer continue with the Special Protocol Assessment process.
-
Aug 7th, 2007
New research shows how a particular small molecule blocks the activity of a cancer-suppressing gene, allowing liver-cancer cells to grow and spread.
-
Jul 10th, 2007
The link between eating uncooked fish and liver cancer in South East Asia.
-
Jun 20th, 2007
Adding more good news to last week's announcement that Nexavar (sorafenib) may be the first effective treatment for advanced liver cancer, researchers at the Lombardi Comprehensive Cancer Center at Georgetown University have uncovered a new molecular mechanism that may "spontaneously" cause liver cancer.
-
Jun 4th, 2007
Bayer and Onyx Pharmaceuticals say Nexavar tablets significantly extended overall survival in primary liver cancer versus those taking placebo by 44 percent.
-
Apr 15th, 2007
This is the first study to examine potential biomarkers for early detection of liver cancer in high-risk populations.
